BIOMAT Database Logo BIOMAT Database Logo

Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family. 1996

A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Neurodegenerative Disorders Center, Vancouver Hospital and Health Sciences Center, Vancouver, British Columbia, Canada.

Pallido-ponto-nigral degeneration (PPND) is a dominantly inherited disorder with parkinsonism. We performed PET with [18F]fluorodopa (FD) and, later, gene testing in 12 asymptomatic relatives at risk from a family with PPND and compared the striatal FD uptake constant (Ki) in them with 4 symptomatic individuals and 10 normal control subjects. Four relatives with positive linkage had a significantly reduced Ki from the normal control subjects but to a lesser degree than the symptomatic patients. The mean Ki in the relatives with negative linkage (n = 8) did not differ from normal control subjects. In conclusion, we identified reduced dopaminergic function in asymptomatic relatives with positive genetic linkage from the PPND family. Most of the reduction in this disorder occurs in the fifth decade, when the disease manifests clinically.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011149 Pons The front part of the hindbrain (RHOMBENCEPHALON) that lies between the MEDULLA and the midbrain (MESENCEPHALON) ventral to the cerebellum. It is composed of two parts, the dorsal and the ventral. The pons serves as a relay station for neural pathways between the CEREBELLUM to the CEREBRUM. Pons Varolii,Ponte,Pons Varolius,Pontes,Varolii, Pons,Varolius, Pons
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D005917 Globus Pallidus The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus. Paleostriatum,Pallidum,Pallidums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D014055 Tomography, Emission-Computed Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image. CAT Scan, Radionuclide,CT Scan, Radionuclide,Computerized Emission Tomography,Radionuclide Tomography, Computed,Scintigraphy, Computed Tomographic,Tomography, Radionuclide-Computed,Computed Tomographic Scintigraphy,Emission-Computed Tomography,Radionuclide Computer-Assisted Tomography,Radionuclide Computerized Tomography,Radionuclide-Computed Tomography,Radionuclide-Emission Computed Tomography,Tomography, Computerized Emission,CAT Scans, Radionuclide,CT Scans, Radionuclide,Computed Radionuclide Tomography,Computed Tomography, Radionuclide-Emission,Computer-Assisted Tomographies, Radionuclide,Computer-Assisted Tomography, Radionuclide,Computerized Tomography, Radionuclide,Emission Computed Tomography,Emission Tomography, Computerized,Radionuclide CAT Scan,Radionuclide CAT Scans,Radionuclide CT Scan,Radionuclide CT Scans,Radionuclide Computed Tomography,Radionuclide Computer Assisted Tomography,Radionuclide Computer-Assisted Tomographies,Radionuclide Emission Computed Tomography,Scan, Radionuclide CAT,Scan, Radionuclide CT,Scans, Radionuclide CAT,Scans, Radionuclide CT,Tomographic Scintigraphy, Computed,Tomographies, Radionuclide Computer-Assisted,Tomography, Computed Radionuclide,Tomography, Emission Computed,Tomography, Radionuclide Computed,Tomography, Radionuclide Computer-Assisted,Tomography, Radionuclide Computerized,Tomography, Radionuclide-Emission Computed

Related Publications

A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Myoclonus in pallido-ponto-nigral degeneration.
January 2002, Advances in neurology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Anatomy of disturbed sleep in pallido-ponto-nigral degeneration.
June 2011, Annals of neurology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration.
September 1992, Annals of neurology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Speech characteristics of patients with pallido-ponto-nigral degeneration and their application to presymptomatic detection in at-risk relatives.
August 2006, American journal of speech-language pathology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration").
June 1998, Journal of neuropathology and experimental neurology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Interest in genetic testing in pallido-ponto-nigral degeneration (PPND): a family with frontotemporal dementia with Parkinsonism linked to chromosome 17.
March 2001, European journal of neurology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation.
September 2007, Acta neuropathologica,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration.
September 1998, Electroencephalography and clinical neurophysiology,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.
October 1998, Proceedings of the National Academy of Sciences of the United States of America,
A Kishore, and Z K Wszolek, and B J Snow, and R de la Fuente-Fernandez, and F Arwert, and M Wijker, and M Schulzer, and D B Calne, and F J Vingerhoets
Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21.
January 1996, Human molecular genetics,
Copied contents to your clipboard!